OAC in Patients With AF and COVID-19 Lowers Rates of Death, Thrombotic Events
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Researchers sought to determine the amount of residual anticoagulation from apixaban in patients who discontinued the medication prior to surgery
Researchers investigated racial and ethnic disparities in anticoagulation initiation in patients dually enrolled in the Veterans Health Administration and Medicare.
In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.
This study has observed that if atrial fibrillation episodes are brief, the risk of stroke is low.